Ma JC - Search Results

1

The Effect of immunotherapy on oligometastatic non-small cell lung cancer patients by sites of metastasis.

Ma JC, Zhang JX, Wang F, Yu J, Chen D. Ma JC, et al. Front Immunol. 2022 Nov 14;13:1039157. doi: 10.3389/fimmu.2022.1039157. eCollection 2022. Front Immunol. 2022. PMID: 36451822 Free PMC article.

2

Effective Combinations of Immunotherapy and Radiotherapy for Cancer Treatment.

Yu S, Wang Y, He P, Shao B, Liu F, Xiang Z, Yang T, Zeng Y, He T, Ma J, Wang X, Liu L. Yu S, et al. Front Oncol. 2022 Feb 7;12:809304. doi: 10.3389/fonc.2022.809304. eCollection 2022. Front Oncol. 2022. PMID: 35198442 Free PMC article. Review.

3

The Role of Thoracic Vertebral Body Dosimetry in Minimizing Acute Hematologic Toxicities of Patients With Non-Small Cell Lung Cancer Receiving Lung Radiation Therapy and Immunotherapy.

Ma J, Li Y, Yu H, Zhang J, Zhang Y, Verma V, Chen H, Qin X, Zhai X, Shang S, Shangguan J, Wang R, Tian C, Wang F, Yu J, Chen D. Ma J, et al. Int J Radiat Oncol Biol Phys. 2024 May 1;119(1):78-89. doi: 10.1016/j.ijrobp.2023.11.037. Epub 2023 Nov 30. Int J Radiat Oncol Biol Phys. 2024. PMID: 38040058

4

High HPK1⁺PD-1⁺TIM-3⁺CD8⁺ T cells infiltration predicts poor prognosis to immunotherapy in NSCLC patients.

Zhang J, Ren Z, Hu Y, Shang S, Wang R, Ma J, Zhang Z, Wu M, Wang F, Yu J, Chen D. Zhang J, et al. Int Immunopharmacol. 2024 Jan 25;127:111363. doi: 10.1016/j.intimp.2023.111363. Epub 2023 Dec 15. Int Immunopharmacol. 2024. PMID: 38101218

5

In Reply To Z. Ma et al.

Ma J, Yang H, Wang F, Wu M, Yu J, Chen D. Ma J, et al. Int J Radiat Oncol Biol Phys. 2024 Jul 1;119(3):1024-1025. doi: 10.1016/j.ijrobp.2024.02.028. Int J Radiat Oncol Biol Phys. 2024. PMID: 38851258 No abstract available.

6

The AST/ALT ratio predicts survival and improves oncological therapy decisions in patients with non-small cell lung cancer receiving immunotherapy with or without radiotherapy.

Zhang Y, Zhang J, Shang S, Ma J, Wang F, Wu M, Yu J, Chen D. Zhang Y, et al. Front Oncol. 2024 Aug 26;14:1389804. doi: 10.3389/fonc.2024.1389804. eCollection 2024. Front Oncol. 2024. PMID: 39252939 Free PMC article.

7

The comparison of prognostic value of tumour volumetric regression ratio and RECIST 1.1 criteria after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.

Zeng YY, Xiang ZZ, He T, Liu F, Shao BF, Yan RN, Ma JC, Wang XR, Liu L. Zeng YY, et al. Among authors: ma jc. Oral Oncol. 2020 Dec;111:104924. doi: 10.1016/j.oraloncology.2020.104924. Epub 2020 Jul 28. Oral Oncol. 2020. PMID: 32736209

8

The Effect of Postmastectomy Radiotherapy on Breast Cancer Patients After Neoadjuvant Chemotherapy by Molecular Subtype.

Ma JC, Zhong XR, Luo T, Xiang ZZ, Li JY, Luo C, Yan X, He P, Tian TL, Liu F, Liu L, Zheng H. Ma JC, et al. Ann Surg Oncol. 2021 Sep;28(9):5084-5095. doi: 10.1245/s10434-020-09523-1. Epub 2021 Feb 12. Ann Surg Oncol. 2021. PMID: 33580420

9

The prognostic value of volumetric reduction of the target lesions after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.

Xiang ZZ, Liu F, Yan RN, Zeng YY, He T, Zeng Z, Zhu ZH, Bai L, Ma JC, Liu L. Xiang ZZ, et al. Among authors: ma jc. Head Neck. 2019 Jun;41(6):1863-1872. doi: 10.1002/hed.25620. Epub 2019 Jan 8. Head Neck. 2019. PMID: 30620441

10

The Clinical Application of 3D-Printed Boluses in Superficial Tumor Radiotherapy.

Wang X, Wang X, Xiang Z, Zeng Y, Liu F, Shao B, He T, Ma J, Yu S, Liu L. Wang X, et al. Front Oncol. 2021 Aug 19;11:698773. doi: 10.3389/fonc.2021.698773. eCollection 2021. Front Oncol. 2021. PMID: 34490095 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

260 results

Search Page

Filters